English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

OBJECTIVES: To determine the safety and efficacy of Misoprostol for induction of labour in a secondary care set up. DESIGN: Quasi experimental study. SETTING: Labour ward at Aga Khan Maternal and Child Care Center, Hyderabad - Sindh, Pakistan from September 2005 to May 2006. METHODS: Forty women having singleton pregnancy, with indication for induction of labour were enrolled for this study. After a verbal consent, 100 mgm of Misoprostol (1/2 Tablet Cytotec, Searle & Co. Chicago) was inserted in posterior vaginal fornix and repeated every 6 hourly for a maximum of 3 doses or initiation of active labour. Induction failure, caesarean delivery, uterine hyperstimulation and rupture, and the neonatal outcome were main outcome measures. Data were collected through a pre-designed proforma and analyzed through SPSS software version 10.0. RESULTS: Labour was successfully completed in 35(87.5%) women, even when Bishop’s score was <4. Induction failure was noted in 2(5%) women, however, no case of uterine rupture or severe birth asphyxia was found. Out of these 35 women, 12(31.6%) delivered within 7-8 hours of initiation of labour. Labour was initiated with 2 doses of 100 mgm Misoprostol in 17(42.5%) cases. CONCLUSION: Misoprostol seems to be a safe and effective agent for induction of labour. However, these results should be interpretted with caution because of limited number of women in this series.

Misoprostol For Induction Of Labour: The Hyderabad Experience